Dual-targeting strategy using trastuzumab and lapatinib in a patient with HER2 gene amplification in recurrent metachronous metastatic gallbladder carcinoma

Gallbladder carcinoma (GBC) is a rare and highly aggressive tumor. Early diagnosis is challenging, which results in a poor prognosis using systemic therapy. Recent studies have identified a subset of GBC patients with HER2 gene (ERBB2) amplification that could benefit from HER2-targeted therapy. Her...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Int Med Res
Main Authors: Ye, Minfeng, Lv, Jieqing, Xu, Guangen, Wang, Wei, Jing, Yuanming, Sun, Aijing, Lu, Zengxin, Wu, Xue, Liu, Yichuan, Shao, Yang W., Liu, Fang, Tao, Feng
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Case Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6567708/
https://ncbi.nlm.nih.gov/pubmed/31106632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060519847796
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados